Personalized high-dose radiation for Ewing sarcoma
Part of Cancer clinical trials.
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Ewing sarcoma (or a similar type called Ewing-like sarcoma).
- You must be at least 2 years old.
- You must be well enough to carry out your daily activities (a score of 70 or higher on a function scale).
- You must be willing to give blood samples and, if the tumor is large (8 cm or more), a tissue sample for research.
- You cannot have had chemotherapy or radiation that would interfere with the trial, or have another active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving radiation therapy before surgery helps people with high-risk Ewing sarcoma. The goal is to make surgery more effective and possibly improve outcomes.
This study is testing new drugs for young people (ages 10 and up) with Ewing sarcoma or related tumors that have come back or stopped responding to treatment. The goal is to find promising drugs that may help shrink tumors or slow their growth.
This trial tests an experimental drug, KC1036, for adolescents with advanced Ewing sarcoma that has not responded to other treatments. It aims to see if the drug can help shrink tumors or slow the cancer.
This trial tests a new type of immunotherapy that targets a specific genetic change in Ewing sarcoma and a related rare tumor called DSRCT. It may be an option for patients whose cancer has come back, spread, or is very high-risk after standard chemotherapy.
This study is testing whether a blood test called ProGRP can help doctors see how well treatment is working in people with Ewing sarcoma. If you are newly diagnosed and are about to start your first treatment, this study may help improve how we track your progress.
This study looks at past patient records to understand what factors affect outcomes and how radiation therapy (high-energy beams to kill cancer cells) helps people with Ewing sarcoma. If you were treated for this bone cancer in the past, your data could help improve treatment for others.
Hear when a new Ewing Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.